IMO-14

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIMO-14
Drug Alias Nameinsulin sensitizer (Dia-B Tech)IMO-14
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPallane Medical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPallane Medical
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A